LIPID A COMPOSITION AS IMMUNOGENIC AGENTS TO PREVENT OR TREAT GRAM-NEGATIVE BACTERIAL INFECTIONS

摘要

This invention is directed to the production of antibodies against lipid A by using encapsulating slow-releasing delivery materials or devices containing concentrations of lipid A that are greater than could be given safely to humans in the absence of said materials or devices. The antibodies to lipid A can be used for binding the antibodies to the lipid A that is present in the lipopolysaccharide that coats the surface of the Gram-negative bacteria.